Literature DB >> 24633617

Skin barrier defects in atopic dermatitis.

Rachana Agrawal1, Judith A Woodfolk.   

Abstract

Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex etiology that is dependent upon interactions between the host and the environment. Acute skin lesions exhibit the features of a Th2-driven inflammatory disorder, and many patients are highly atopic. The skin barrier plays key roles in immune surveillance and homeostasis, and in preventing penetration of microbial products and allergens. Defects that compromise the structural integrity or else the immune function of the skin barrier play a pivotal role in the pathogenesis of AD. This article provides an overview of the array of molecular building blocks that are essential to maintaining healthy skin. The basis for structural defects in the skin is discussed in relation to AD, with an emphasis on filaggrin and its genetic underpinnings. Aspects of innate immunity, including the role of antimicrobial peptides and proteases, are also discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24633617      PMCID: PMC4034059          DOI: 10.1007/s11882-014-0433-9

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  115 in total

Review 1.  Barriers and more: functions of tight junction proteins in the skin.

Authors:  Nina Kirschner; Johanna M Brandner
Journal:  Ann N Y Acad Sci       Date:  2012-06       Impact factor: 5.691

Review 2.  Tight junctions/adherens junctions: basic structure and function.

Authors:  Carien M Niessen
Journal:  J Invest Dermatol       Date:  2007-11       Impact factor: 8.551

3.  Membrane-coating granules in "dry" non-eczematous skin of patients with atopic dermatitis. A quantitative electron microscopic study.

Authors:  Y Werner; M Lindberg; B Forslind
Journal:  Acta Derm Venereol       Date:  1987       Impact factor: 4.437

4.  Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis.

Authors:  Anna De Benedetto; Mark K Slifka; Nicholas M Rafaels; I-Hsin Kuo; Steve N Georas; Mark Boguniewicz; Tissa Hata; Lynda C Schneider; Jon M Hanifin; Richard L Gallo; David C Johnson; Kathleen C Barnes; Donald Y M Leung; Lisa A Beck
Journal:  J Allergy Clin Immunol       Date:  2011-04-13       Impact factor: 10.793

5.  Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.

Authors:  Jörg Buddenkotte; Christopher Stroh; Ingo H Engels; Corinna Moormann; Victoria M Shpacovitch; Stephan Seeliger; Nathalie Vergnolle; Dietmar Vestweber; Thomas A Luger; Klaus Schulze-Osthoff; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2005-01       Impact factor: 8.551

6.  History of eczema herpeticum is associated with the inability to induce human β-defensin (HBD)-2, HBD-3 and cathelicidin in the skin of patients with atopic dermatitis.

Authors:  T R Hata; P Kotol; M Boguniewicz; P Taylor; A Paik; M Jackson; M Nguyen; F Kabigting; J Miller; M Gerber; D Zaccaro; B Armstrong; R Dorschner; D Y M Leung; R L Gallo
Journal:  Br J Dermatol       Date:  2010-06-09       Impact factor: 9.302

7.  IL-31 regulates differentiation and filaggrin expression in human organotypic skin models.

Authors:  Christian Cornelissen; Yvonne Marquardt; Katharina Czaja; Jörg Wenzel; Jorge Frank; Juliane Lüscher-Firzlaff; Bernhard Lüscher; Jens M Baron
Journal:  J Allergy Clin Immunol       Date:  2011-12-15       Impact factor: 10.793

8.  Electron diffraction study of lipids in non-lesional stratum corneum of atopic eczema patients.

Authors:  M Janssens; A A Mulder; J van Smeden; G S K Pilgram; R Wolterbeek; A P M Lavrijsen; R I Koning; A J Koster; J A Bouwstra
Journal:  Biochim Biophys Acta       Date:  2013-04-11

9.  Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis.

Authors:  S Asano; Y Ichikawa; T Kumagai; M Kawashima; G Imokawa
Journal:  Br J Dermatol       Date:  2008-07-01       Impact factor: 9.302

10.  Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood.

Authors:  Jonathan N W N Barker; Colin N A Palmer; Yiwei Zhao; Haihui Liao; Peter R Hull; Simon P Lee; Michael H Allen; Simon J Meggitt; Nicholas J Reynolds; Richard C Trembath; W H Irwin McLean
Journal:  J Invest Dermatol       Date:  2006-09-21       Impact factor: 8.551

View more
  47 in total

1.  Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.

Authors:  Hitokazu Esaki; David A Ewald; Benjamin Ungar; Mariya Rozenblit; Xiuzhong Zheng; Hui Xu; Yeriel D Estrada; Xiangyu Peng; Hiroshi Mitsui; Thomas Litman; Mayte Suárez-Fariñas; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-01       Impact factor: 10.793

Review 2.  The Skin as a Route of Allergen Exposure: Part I. Immune Components and Mechanisms.

Authors:  Anna R Smith; George Knaysi; Jeffrey M Wilson; Julia A Wisniewski
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

3.  Do young adults with atopic dermatitis avoid harmful workplace exposure at their first job? A prospective cohort study.

Authors:  Junxiang Wei; Jessica Gerlich; Christian Vogelberg; Erika von Mutius; Doris Windstetter; Jon Genuneit; Gudrun Weinmayr; Dennis Nowak; Katja Radon
Journal:  Int Arch Occup Environ Health       Date:  2015-07-19       Impact factor: 3.015

Review 4.  The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Authors:  Yuliya Skabytska; Susanne Kaesler; Thomas Volz; Tilo Biedermann
Journal:  Semin Immunopathol       Date:  2015-11-16       Impact factor: 9.623

5.  Model learning analysis of 3D optoacoustic mesoscopy images for the classification of atopic dermatitis.

Authors:  Sojeong Park; Shier Nee Saw; Xiuting Li; Mahsa Paknezhad; Davide Coppola; U S Dinish; Amalina Binite Ebrahim Attia; Yik Weng Yew; Steven Tien Guan Thng; Hwee Kuan Lee; Malini Olivo
Journal:  Biomed Opt Express       Date:  2021-05-27       Impact factor: 3.732

Review 6.  Staphylococcal Biofilms in Atopic Dermatitis.

Authors:  Tammy Gonzalez; Jocelyn M Biagini Myers; Andrew B Herr; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-23       Impact factor: 4.806

Review 7.  Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins.

Authors:  Jolanda H M van Bilsen; Edyta Sienkiewicz-Szłapka; Daniel Lozano-Ojalvo; Linette E M Willemsen; Celia M Antunes; Elena Molina; Joost J Smit; Barbara Wróblewska; Harry J Wichers; Edward F Knol; Gregory S Ladics; Raymond H H Pieters; Sandra Denery-Papini; Yvonne M Vissers; Simona L Bavaro; Colette Larré; Kitty C M Verhoeckx; Erwin L Roggen
Journal:  Clin Transl Allergy       Date:  2017-05-12       Impact factor: 5.871

Review 8.  Experimental Drugs with the Potential to Treat Atopic Eczema.

Authors:  Kam Lun Ellis Hon; Vivian P Y Chan; Alexander K C Leung
Journal:  J Exp Pharmacol       Date:  2021-05-12

9.  Biofilm propensity of Staphylococcus aureus skin isolates is associated with increased atopic dermatitis severity and barrier dysfunction in the MPAACH pediatric cohort.

Authors:  Tammy Gonzalez; Mariana L Stevens; Asel Baatyrbek Kyzy; Rosario Alarcon; Hua He; John W Kroner; Daniel Spagna; Brittany Grashel; Elaine Sidler; Lisa J Martin; Jocelyn M Biagini Myers; Gurjit K Khurana Hershey; Andrew B Herr
Journal:  Allergy       Date:  2020-08-09       Impact factor: 13.146

10.  Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis.

Authors:  Srinita Banerjee; Yvonne Resch; Kuan-Wei Chen; Ines Swoboda; Margit Focke-Tejkl; Katharina Blatt; Natalija Novak; Magnus Wickman; Marianne van Hage; Rosetta Ferrara; Adriano Mari; Ashok Purohit; Gabrielle Pauli; Elopy N Sibanda; Portia Ndlovu; Wayne R Thomas; Vladislav Krzyzanek; Sebastian Tacke; Ursula Malkus; Peter Valent; Rudolf Valenta; Susanne Vrtala
Journal:  J Invest Dermatol       Date:  2014-08-07       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.